Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BM.1.1.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BM.1.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BM.1.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BM.1.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.2.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BM.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.2.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BM.2.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BM.2.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BM.2.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BM.2.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BM.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CW.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CW.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CW.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CW.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CW.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CW.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CW.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CW.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.42EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.42EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.42ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.2.42ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.2.42EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.2.42EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.42ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.42ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.63EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.63EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.63ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.2.63ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.2.63EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.2.63EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.63ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.63ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FM.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
FM.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FM.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
FM.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FM.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FM.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FM.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FM.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.4.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GA.4.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.4.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GA.4.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GA.4.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GA.4.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used